Journal Club with Dr. Peter Attia | Metformin for Longevity & The Power of Belief Effects

Summary

Dr. Peter Attia discusses the potential role of Metformin in longevity and the power of belief effects in neurobiology and placebos. He compares the findings on Metformin to previous research and advises on its usage based on the data. Andrew Huberman presents a paper on the placebo effect, showing that it can follow a dose response. The degree of placebo effect can be scaled depending on the perceived dosage of a drug. Metformin is a drug commonly used to treat type 2 diabetes by reducing glucose production in the liver. It has potential geroprotective effects and may offer additional benefits beyond glucose regulation. The TAME Trial is investigating the potential longevity benefits of Metformin. The mortality rate associated with Metformin usage is discussed, but it cannot be concluded that Metformin directly causes higher mortality rates. The video also explores the impact of beliefs on medication effectiveness and the potential benefits of other substances like Berberine and Acarbose. The relationship between biology and beliefs is explored, particularly in relation to nicotine and dopamine response. The video emphasizes the importance of understanding beliefs in healthcare and provides tips for effectively reading journal articles.

Have questions about the video? Create a FREE account to ask Wiz AI

7 days free trial